🔥Telegram İfşa

Proud to announce the launch of #ChamishiTherapeutics in collaboration with @QStateBio #CureGBA #Chamishi #ASOs #antisense #CureParkinsons silversteinfoundation.org/2019/09/25/the…

Patrik Brundin MD PhD Benjamin Stecher We are making some bold assumptions with the current stock of GBA-#Parkinsons trials. A lot of questions regarding our understanding of that 'sub-type' will be answered by those trials. But while those trials play out (with significant support from groups like Silverstein FNDN..

Interesting new clinical trial registered by Pacific Parkinson's Research Institute with support from michaeljfox.org & Silverstein FNDN to analyze the molecular & clinical mechanisms of the relationship between the GBA mutations & #Parkinsons clinicaltrials.gov/ct2/show/NCT04…

This is a Silverstein FNDN-supported project, which we have previously discussed on the SoPD website: scienceofparkinsons.com/2019/06/21/pre…

New company Surmount Bio has been set up to explore & develop S-181 further. Backed by Silverstein FNDN-associated OrbiMed - Wow, a lot happening in the GBA-#Parkinsons world! Prevail, Surmount,... what next?

Last week the Silverstein FNDN held it’s 3rd annual Scientific Advisory Board meeting, focusing on 8 different therapeutic approaches that we have funded. In all, we have made 32 grants since our launch in 2017. We will put our 3rd drug into human trials in mid-Nov. #cureGBA

The michaeljfox.org featured #PrevailTherapeutics in a blog post announcing recruitment for the PROPEL trial, a #genetherapy clinical trial for PD patients with a GBA mutation. Read the blog here: bit.ly/36lQyyf Learn more about the trial here: bit.ly/2qYnFrT

Herbert Aberson Just a few of the programs that will forever change PD (& more) in the decade to come... Silverstein FNDN Cure Parkinson's's LCT The Neuro's OS @C_R_A_N_I_A Structural Genomics Consortium (SGC) ASAP (needs @ Ekemini A. U. Riley ;) CCBP (ditto) LashuelNeuroLab CZI Science Allen Institute Alastair Noyce PDgenetics.org

Today is #GivingTuesday a global generosity movement for giving to the causes you care most about. Help us beat Parkinson's #Parkinsons #cureGBA silversteinfoundation.org/donate

Exciting News from The Silverstein Foundation conta.cc/3aaMF3G

We are proud to announce another transformative grant in Parkinson’s with GBA globenewswire.com/news-release/2…

More #Funding & #Grants DnaNudge completion of $60M #SeriesA #Investment Led by #VenturaCapital Oxford BioDynamics awarded #FNIH #grant for applications for to apply #EpiSwitch® #ImmuneHealth test #Cancer #Therapies Silverstein FNDN funding for #AcureXTherapeutics #Parkinsons

"Vanqua Bio is helping usher in a new era of hope for people living with neurodegenerative disorders.” - Jim Sullivan, PhD, Co-founder and CEO of Vanqua Bio

Proud of this announcement and our partnership with Vanqua Bio

New clinical study registered: @ScottNYSCF & colleagues at the New York Stem Cell Foundation Research Institute & Silverstein FNDN are seeking skin biopsies &/or blood cells from people with GBA-associated #Parkinsons for drug discovery projects clinicaltrials.gov/ct2/show/NCT05…

We are excited to announce our new Post-Doctoral Fellowship Program today. #cureGBAPD businesswire.com/news/home/2023…

One of the best ways to invest in research is to invest in people. I'm very grateful that the Silverstein FNDN have selected us as one of the centers to receive funding for a 2-years fellowship to study GBA1. Please contact me if you are interested. businesswire.com/news/home/2023…

The Silverstein Foundation Silverstein FNDN launches a program of 2-year, post-doctoral fellowships to fund 11 scientists working on novel research for #Parkinsons in GBA mutation carriers businesswire.com/news/home/2023…

The first in-person meeting of The Silverstein Foundation Fellows. All gathered at the GBA1 meeting at The Neuro. Excited to hear updates from all of our fellows. #cureGBAPD

Thank you for having us Ziv Gan-Or! Excited to begin.